Clinical Trial Update: A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101) [EARLY_Phase 1]

View source ↗

Summary

EARLY Phase 1 clinical trial update for DSL101, an ATP7B mRNA/LNP therapy for Wilson disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilson Disease

Drugs mentioned

• DSL101 (ATP7B mRNA in lipid nanoparticles)

Snippet

Sponsor: DSciLab Co., Ltd. | Conditions: Wilsons Disease | EARLY_Phase 1 | Status: RECRUITING